This patient's tumor transformed in situ from adenocarcinoma to poorly differentiated squamous cell carcinoma with SMARCA4 loss, and the current reasonable hypothesis is a branched evolutionary model with cells of common origin,19, 20 i.e., there is a precursor cell at baseline that can transform into another phenotype in response to TKI treatment. This evidence concerns the gene SMARCA4 and neoplasm.